In this study, MMP9, SPP1, HAGLR, LINC02202, and RP11-598F7.3 are considered as potential diagnostic biomarkers for hepatocellular carcinoma, and CD4+ memory resting T cells and CD8+ T cells are believed to be involved in HCC immune control. The gene discussed is CD8A; the disease is hepatocellular carcinoma.